drugset / Trial / NCT02058095

Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)

NCT02058095

Phase 1/2 Completed 22 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindBasic science

Summary

To determine the effect of 12 weeks of chronic PDEV inhibition with Tadalafil versus placebo on basal cardiorenal and humoral function and on the integrated cardiorenal and humoral response to acute sodium loading in subjects with preclinical Diastolic dysfunction (PDD) and renal (kidney) dysfunction

Timeline

Start
2014-03
Primary completion
2019-06
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral